Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Boshi Antai Technology Development is a Chinese medical technology company that specializes in the distribution and development of in vitro diagnostic (IVD) reagents and laboratory equipment. Founded in 2004 and headquartered in Beijing, the company provides a range of products including clinical chemistry analyzers, immunological diagnostic kits, and molecular biology reagents. They serve a broad client base consisting of hospitals, blood centers, and research laboratories across China. In addition to product sales, the company offers technical consulting and after-sales support for laboratory automation systems. Boshi Antai is positioned as a key player in the regional diagnostic supply chain, focusing on improving the efficiency and accuracy of clinical testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Boshi Antai Technology Development.